BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1342 related articles for article (PubMed ID: 11266382)

  • 1. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
    Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
    Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.
    Chalasani N; Deeg MA; Persohn S; Crabb DW
    Am J Gastroenterol; 2003 Aug; 98(8):1849-55. PubMed ID: 12907343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
    Chalasani N; Deeg MA; Crabb DW
    Am J Gastroenterol; 2004 Aug; 99(8):1497-502. PubMed ID: 15307867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel use of the hyperinsulinemic-euglycemic clamp technique to estimate insulin sensitivity of systemic lipolysis.
    Stumvoll M; Wahl HG; Löblein K; Becker R; Volk A; Renn W; Jacob S; Häring H
    Horm Metab Res; 2001 Feb; 33(2):89-95. PubMed ID: 11294499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
    Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
    Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
    Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
    Li L; Yang GY
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
    Pérez-Carreras M; Del Hoyo P; Martín MA; Rubio JC; Martín A; Castellano G; Colina F; Arenas J; Solis-Herruzo JA
    Hepatology; 2003 Oct; 38(4):999-1007. PubMed ID: 14512887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fat and lipid oxidation in humans.
    Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
    Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH).
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(2):377-9. PubMed ID: 15922116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
    Matsunami T; Sato Y; Ariga S; Sato T; Shimomura T; Kashimura H; Hasegawa Y; Yukawa M
    Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis.
    Piro S; Spadaro L; Russello M; Spampinato D; Oliveri CE; Vasquez E; Benigno R; Brancato F; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):545-52. PubMed ID: 18063353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK; van de Werve G; Giacca A
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
    Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
    Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.